Fenge Li

1.5k total citations
31 papers, 1.1k citations indexed

About

Fenge Li is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Fenge Li has authored 31 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Immunology, 11 papers in Oncology and 7 papers in Molecular Biology. Recurrent topics in Fenge Li's work include Immunotherapy and Immune Responses (10 papers), Cancer Immunotherapy and Biomarkers (8 papers) and CAR-T cell therapy research (5 papers). Fenge Li is often cited by papers focused on Immunotherapy and Immune Responses (10 papers), Cancer Immunotherapy and Biomarkers (8 papers) and CAR-T cell therapy research (5 papers). Fenge Li collaborates with scholars based in China, United States and Germany. Fenge Li's co-authors include Gregory Lizée, Jennifer L. Krauss, George Hajishengallis, Martina Rauner, Toshiharu Abe, Michael A. Curtis, Jindrǐch Chmelař, Lorenz C. Hofbauer, Eun Young Choi and Shuang Liang and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Fenge Li

28 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fenge Li China 14 507 329 296 280 147 31 1.1k
Sayuri Miyauchi United States 17 461 0.9× 348 1.1× 358 1.2× 182 0.7× 151 1.0× 37 1.0k
Josephine Meade United Kingdom 16 546 1.1× 269 0.8× 297 1.0× 279 1.0× 52 0.4× 26 1.2k
Sofia Z. Raptis United States 8 504 1.0× 314 1.0× 234 0.8× 64 0.2× 286 1.9× 10 1.0k
Donghang Zheng United States 18 180 0.4× 401 1.2× 166 0.6× 358 1.3× 158 1.1× 27 1.2k
Yufeng Xie China 23 620 1.2× 1.0k 3.1× 264 0.9× 120 0.4× 466 3.2× 58 1.6k
Ying-Tai Jin Taiwan 21 353 0.7× 418 1.3× 572 1.9× 59 0.2× 179 1.2× 33 1.3k
Mark Dixon United Kingdom 11 270 0.5× 188 0.6× 155 0.5× 383 1.4× 53 0.4× 19 757
Ellen Moore United States 23 796 1.6× 334 1.0× 787 2.7× 70 0.3× 88 0.6× 48 1.6k
Helga Schmetzer Germany 22 886 1.7× 330 1.0× 472 1.6× 28 0.1× 86 0.6× 93 1.4k
Bernard Grillet Netherlands 21 463 0.9× 225 0.7× 336 1.1× 19 0.1× 209 1.4× 42 1.6k

Countries citing papers authored by Fenge Li

Since Specialization
Citations

This map shows the geographic impact of Fenge Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fenge Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fenge Li more than expected).

Fields of papers citing papers by Fenge Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fenge Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fenge Li. The network helps show where Fenge Li may publish in the future.

Co-authorship network of co-authors of Fenge Li

This figure shows the co-authorship network connecting the top 25 collaborators of Fenge Li. A scholar is included among the top collaborators of Fenge Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fenge Li. Fenge Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liang, Qiqi, S. Jin, Jinmei Huang, et al.. (2025). MFMGP: an integrated machine learning fusion model for genomic prediction. Plant Biotechnology Journal. 23(3). 712–714. 1 indexed citations
2.
Li, Fenge, et al.. (2025). Nicotinamide adenine dinucleotide alleviates neuroinflammation in rats with traumatic brain injury. Neuroscience Letters. 852. 138178–138178.
3.
Li, Fenge, et al.. (2024). Autologous Tumor-Infiltrating Lymphocyte Mono-Therapy Can Rapidly Shrank Tumor in Asian Patient with Stage III/IV Cervical Cancer: Two Cases Report. International Journal of Women s Health. Volume 16. 31–39. 3 indexed citations
4.
Li, Fenge, et al.. (2024). Prognostic significance of peripheral and tumor-infiltrating lymphocytes in newly diagnosed stage III/IV non-small-cell lung cancer. Frontiers in Medicine. 11. 1349178–1349178. 1 indexed citations
5.
Li, Fenge. (2024). A Review of Hydrogen-powered Aircraft. 23. 409–418. 1 indexed citations
7.
Li, Xiaolin, Xuehui Zhang, Yupeng Wang, et al.. (2023). The Cervicovaginal Expression Level of Interleukin-6 Can be a Prediction Factor for Cervical Intraepithelial Neoplasias and Cervical Cancer: A Prospective Cohort Study. SHILAP Revista de lepidopterología. 50(11). 1 indexed citations
8.
Li, Hongli, Luqing Wei, & Fenge Li. (2023). Diagnosis of mycobacterium avium complex infection utilizing metagenomics next-generation sequencing: a case report. Frontiers in Medicine. 10. 1247034–1247034. 2 indexed citations
10.
Li, Fenge, et al.. (2021). Evolution of CD8+ T Cell Receptor (TCR) Engineered Therapies for the Treatment of Cancer. Cells. 10(9). 2379–2379. 31 indexed citations
12.
Cao, Qizhen, Wanqin Wang, Min Zhou, et al.. (2020). Induction of antitumor immunity in mice by the combination of nanoparticle-based photothermolysis and anti-PD-1 checkpoint inhibition. Nanomedicine Nanotechnology Biology and Medicine. 25. 102169–102169. 30 indexed citations
13.
Jiang, Danye, et al.. (2020). C1q Regulates Horizontal Cell Neurite Confinement in the Outer Retina. Frontiers in Neural Circuits. 14. 583391–583391. 13 indexed citations
14.
Guo, Yu, Ping Wang, Peng‐Hui Wang, et al.. (2017). Myometrial invasion and overall staging of endometrial carcinoma: assessment using fusion of T2-weighted magnetic resonance imaging and diffusion-weighted magnetic resonance imaging. OncoTargets and Therapy. Volume 10. 5937–5943. 25 indexed citations
15.
Bradley, Sherille D., Zeming Chen, Brenda Melendez, et al.. (2015). BRAFV600E Co-opts a Conserved MHC Class I Internalization Pathway to Diminish Antigen Presentation and CD8+ T-cell Recognition of Melanoma. Cancer Immunology Research. 3(6). 602–609. 124 indexed citations
16.
Ma, Xiaodong, Daniel J. Conklin, Fenge Li, et al.. (2015). The oncogenic microRNA miR-21 promotes regulated necrosis in mice. Nature Communications. 6(1). 7151–7151. 83 indexed citations
17.
Ma, Xiaodong, Fang Yan, Qipan Deng, et al.. (2015). Modulation of tumorigenesis by the pro-inflammatory microRNA miR-301a in mouse models of lung cancer and colorectal cancer. Cell Discovery. 1(1). 15005–15005. 38 indexed citations
18.
Zhou, Dapeng, Shailbala Singh, Wei Song, et al.. (2014). Sublingual injection of microparticles containing glycolipid ligands for NKT cells and subunit vaccines induces antibody responses in oral cavity. Carbohydrate Research. 405. 87–92. 4 indexed citations
19.
Tao, Hu, Shuqi Mei, Xianwen Peng, et al.. (2013). Associations of TCF12, CTNNAL1 and WNT10B gene polymorphisms with litter size in pigs. Animal Reproduction Science. 140(3-4). 189–194. 18 indexed citations
20.
Eskan, Mehmet A., Ravi Jotwani, Toshiharu Abe, et al.. (2012). The leukocyte integrin antagonist Del-1 inhibits IL-17-mediated inflammatory bone loss. Nature Immunology. 13(5). 465–473. 347 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026